Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-01 Sale | 2024-08-02 4:05 pm | Cara Therapeutics Inc. | CARA | Posner Christopher PRESIDENT AND CEO | 4,149 | $0.35 | $1,452 | 172,436 (Direct) | View |
| 2024-05-02 Sale | 2024-05-06 4:15 pm | Cara Therapeutics Inc. | CARA | Posner Christopher PRESIDENT AND CEO | 3,936 | $0.75 | $2,952 | 176,585 (Direct) | View |
| 2024-02-29 Sale | 2024-03-04 4:19 pm | Cara Therapeutics Inc. | CARA | Posner Christopher PRESIDENT AND CEO | 5,834 | $0.89 | $5,192 | 180,521 (Direct) | View |
| 2024-02-08 Sale | 2024-02-12 5:10 pm | Cara Therapeutics Inc. | CARA | Posner Christopher PRESIDENT AND CEO | 35,575 | $0.53 | $18,855 | 186,355 (Direct) | View |
| 2024-02-01 Sale | 2024-02-05 4:26 pm | Cara Therapeutics Inc. | CARA | Posner Christopher PRESIDENT AND CEO | 4,981 | $0.55 | $2,740 | 221,930 (Direct) | View |
| 2023-11-02 Sale | 2023-11-03 4:37 pm | Cara Therapeutics Inc. | CARA | Posner Christopher President and CEO | 3,796 | $1.22 | $4,631 | 164,411 (Direct) | View |
| 2023-08-03 Sale | 2023-08-04 5:21 pm | Cara Therapeutics Inc. | CARA | Posner Christopher President and CEO | 4,307 | $3.07 | $13,222 | 168,207 (Direct) | View |
| 2023-05-05 Sale | 2023-05-09 4:22 pm | Cara Therapeutics Inc. | CARA | Posner Christopher President and CEO | 3,869 | $4.4 | $17,024 | 172,514 (Direct) | View |
| 2023-03-03 Sale | 2023-03-07 4:47 pm | Cara Therapeutics Inc. | CARA | Posner Christopher President and CEO | 5,987 | $9.71 | $58,134 | 176,383 (Direct) | View |
| 2023-02-02 Sale | 2023-02-03 6:38 pm | Cara Therapeutics Inc. | CARA | Posner Christopher President and CEO | 4,191 | $11.8 | $49,454 | 182,370 (Direct) | View |
| 2022-11-16 Sale | 2022-11-18 5:23 pm | Cara Therapeutics Inc. | CARA | Posner Christopher President and CEO | 14,470 | $11.13 | $161,051 | 186,561 (Direct) | View |
| 2022-04-04 Sale | 2022-04-05 5:48 pm | Cara Therapeutics Inc. | CARA | Posner Christopher President and CEO | 2,006 | $12.67 | $25,416 | 201,031 (Direct) | View |
| 2021-06-07 Sale | 2021-06-07 7:33 pm | Cara Therapeutics Inc. | CARA | Posner Christopher Director | 2,304 | $13.04 | $30,044 | 26,896 (Direct) | View |
| 2020-11-19 Sale | 2020-11-23 8:28 pm | Cara Therapeutics Inc. | CARA | Posner Christopher Director | 2,000 | $15.82 | $31,638 | 11,200 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-01 Option Award | 2024-02-05 4:26 pm | N/A N/A | Cara Therapeutics Inc. | CARA | Posner Christopher PRESIDENT AND CEO | 62,500 | $0 | 221,930 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 4:35 pm | N/A 2033-03-01 | Cara Therapeutics Inc. | CARA | Posner Christopher President and CEO | 250,000 | $0 | 250,000 (Direct) | View |
Ownership | 2022-11-30 4:40 pm | N/A 2032-11-27 | KEMPHARM INC | KMPH | Posner Christopher Director | 0 | $0 | 22,500 (Direct) | View |
| 2022-02-25 Option Award | 2022-03-01 4:17 pm | N/A 2032-02-25 | Cara Therapeutics Inc. | CARA | Posner Christopher President and CEO | 160,000 | $0 | 324,037 (Direct) | View |
| 2021-10-29 Option Award | 2021-11-03 08:15 am | N/A 2031-10-29 | Cara Therapeutics Inc. | CARA | Posner Christopher Senior Advisor | 713,941 | $0 | 730,037 (Direct) | View |
| 2021-06-03 Option Award | 2021-06-07 7:33 pm | N/A 2031-06-03 | Cara Therapeutics Inc. | CARA | Posner Christopher Director | 18,000 | $0 | 26,896 (Direct) | View |
| 2020-06-04 Option Award | 2020-06-08 5:46 pm | N/A 2030-06-04 | Cara Therapeutics Inc. | CARA | Posner Christopher Director | 18,000 | $0 | 24,000 (Direct) | View |